Affibody

Affibody gets izokibep ‘back on track’ after Acelyrin rejection

Affibody may not have expected to be working on izokibep again, but the Swedish biotech hasn’t wasted an opportunity to showcase the drug’s potential.

James Waldron Jun 5, 2026 10:42am

Affibody regains drug, says ex-ally unable to capitalize on data

Feb 3, 2025 5:18am

A doctor with a graphic representation of the lungs

Chiesi, Affibody sign $637M respiratory disease collab

Mar 7, 2023 11:15am